Investor Relations

Syneron Medical Ltd (ELOS) IR Room

Press Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004

2016 Archives

Total Revenue Grows 15.3% Year-Over-Year; Product Revenue Grows 18.6% Year-Over-Year
In Addition, the United States Patent and Trademark Office (USPTO) Has Issued a Notice of Allowance for US Patent Covering the Technology Used in Profound™.
Strengthens Senior Management Team with High Ranking Aesthetic Industry Veterans
Emerging Products1 Total Revenue Increased 46% Year-Over-Year; Grew to 30% of Total Revenue from 21% in 2Q15
New ultra-short 785nm wavelength is first-of-its-kind in the aesthetic market, enabling comprehensive tattoo removal with PicoWay
UltraShape Power provides a 20% increase in Acoustic Energy; Demonstrates 32% reduction in abdominal fat layer thickness
Emerging Products(1) Total Revenue Increases 34%
Ryan Lochte Gets Hours of Training Back Using Gentle Laser Hair Removal
Industry-leading Physicians Present 11 Abstracts Highlighting Performance and Ease-of-Use of PicoWay, CO2RE, elos® and Profound Technologies
- Syneron Special Offering To Allergan Partner Privileges® Members on Select Syneron Aesthetic Products -
Debuts include the new CO2RE Intima for gynecological and genitourinary indications for vaginal and vulvar health, an additional ultra-short PicoWay laser wavelength for comprehensive tattoo removal and a SubQ Profound applicator for the stimulation of elastin, collagen, hyaluronic acid and the treatment of adipose tissue.
Price Data

print email rss